These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4148923)

  • 1. Proceedings: Alpha-adrenoceptor inhibition from indoramin in man.
    Boakes AJ; Prichard BN; Teoh PC
    Br J Pharmacol; 1972 Feb; 44(2):378P-379P. PubMed ID: 4148923
    [No Abstract]   [Full Text] [Related]  

  • 2. Human pharmacology of indoramin.
    Coltart DJ; Lockhart JD; Royds RB; Turner P
    Br J Pharmacol; 1971 Oct; 43(2):467P-468P. PubMed ID: 4400576
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic studies of indoramin in man.
    Royds RB; Coltart DJ; Lockhart JD
    Clin Pharmacol Ther; 1972; 13(3):380-92. PubMed ID: 4402080
    [No Abstract]   [Full Text] [Related]  

  • 4. Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.
    Fukuta Y; Fukuda Y; Higashino R; Yoshida K; Ogishima M; Tamaki H; Takei M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1013-8. PubMed ID: 10454472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.
    Alps BJ; Johnson ES; Wilson AB
    Br J Pharmacol; 1970 Sep; 40(1):151P-152P. PubMed ID: 4395083
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical pharmacology of indoramin.
    Shanks RG
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S8-15. PubMed ID: 2423804
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of indoramin to induce hypotension during general anaesthesia.
    Paymaster NJ
    Curr Med Res Opin; 1975; 3(1):39-42. PubMed ID: 234825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketanserin and alpha 1-adrenergic antagonism in humans.
    Zabludowski JR; Ball SG; Robertson JI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S123-5. PubMed ID: 2412032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of exercise-induced asthma by indoramin.
    Bianco S; Griffin JP; Kamburoff PL; Prime FJ
    Br Med J; 1974 Oct; 4(5935):18-20. PubMed ID: 4154121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent.
    Royds RB
    Br J Pharmacol; 1972 Feb; 44(2):379P-380P. PubMed ID: 4668635
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological evidence that alpha2A- and alpha2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats.
    Cobos-Puc LE; Villalón CM; Sánchez-López A; Lozano-Cuenca J; Pertz HH; Görnemann T; Centurión D
    Eur J Pharmacol; 2007 Jan; 554(2-3):205-11. PubMed ID: 17109851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha-adrenoceptor blocking effect of indoramin on human isolated smooth muscle.
    Variava DH; Turner P
    J Pharm Pharmacol; 1973 Aug; 25(8):629-32. PubMed ID: 4148431
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha- and beta-adrenoceptor blockade does not affect ventilation during exercise in man.
    Fagard R; Reybrouck T; Lijnen P; Amery A; Moerman E; De Schaepdryver A
    Med Sci Sports Exerc; 1980; 12(5):375-9. PubMed ID: 6109223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of alpha and beta blocker properties of parahydroxybenzonitrile on the cardiovascular system of rats].
    Cheav SL; Kirkiacharian S; Piéri F; Poisson D
    Ann Pharm Fr; 1998; 56(5):205-8. PubMed ID: 9805819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Haemodynamic effects of indoramin: a non-invasive technique for the cardiovascular evaluation of drugs.
    Coltart DJ; Royds RB
    Br J Pharmacol; 1972 Feb; 44(2):387P-388P. PubMed ID: 4668640
    [No Abstract]   [Full Text] [Related]  

  • 17. Peripheral pre and postjunctional alpha 2-adrenoceptors in man: studies with RX781094, a selective alpha 2 antagonist.
    Elliott HL; Jones CR; Reid JL
    J Hypertens Suppl; 1983 Dec; 1(2):109-11. PubMed ID: 6152738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine inhibits the canine external carotid vasodilatation to capsaicin by alpha2A/2C-adrenoceptors.
    Jiménez-Mena LR; Gupta S; Muñoz-Islas E; Lozano-Cuenca J; Sánchez-López A; Centurión D; Mehrotra S; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2006 Aug; 543(1-3):68-76. PubMed ID: 16814767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity.
    Hancock AA; Brune ME; Witte DG; Marsh KC; Katwala S; Milicic I; Ireland LM; Crowell D; Meyer MD; Kerwin JF
    J Pharmacol Exp Ther; 1998 May; 285(2):628-42. PubMed ID: 9580607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic blocking properties of Wy 21901.
    Alps BJ; Hill M; Johnson ES; Wilson AB
    Br J Pharmacol; 1970 Sep; 40(1):153P. PubMed ID: 4395084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.